FUP.F · Fuji Pharma Co., Ltd

-

Please sign in to comment on FUP.F

1 Comment

Admin

4 years ago

Fuji Pharma Co., Ltd is currently in a long term uptrend where the price is trading 6.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.

Fuji Pharma Co., Ltd's total revenue rose by 3.6% to $9B since the same quarter in the previous year.

Its net income has increased by 78.3% to $1B since the same quarter in the previous year.

Based on the above factors, Fuji Pharma Co., Ltd gets an overall score of 4/5.

ISIN	JP3816200004
Exchange	F
CurrencyCode	EUR
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Market Cap	207M
Dividend Yield	3.5%
PE Ratio	7.37
Target Price	None
Beta	0.25

ABOUT

Fuji Pharma Co., Ltd

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.

FUP.F · Fuji Pharma Co., Ltd

-

Fuji Pharma Co., Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Fuji Pharma Co., Ltd using a moving average strategy